Dr. Dimple A Patel, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 59 E Mill Rd Unit 201, Long Valley, NJ 07853 Phone: 908-876-5300 Fax: 908-876-9396 |
Dr. Robert Lawrence Werner, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 16 Schooleys Mountain Rd, Long Valley, NJ 07853 Phone: 908-777-1379 Fax: 803-205-2432 |
Dr. Alan Glicklich, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2 Penny Ln, Long Valley, NJ 07853 Phone: 908-876-4180 |
News Archive
After four years of decreases, medical costs per workers' compensation claim in Texas stabilized in 2007, reflecting the impact of reforms enacted in 2001 and much of those passed in 2005, according to a study by the Workers Compensation Research Institute (WCRI).
Mallinckrodt plc, a leading global specialty pharmaceuticals company, and Cadence Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt plc will commence a tender offer to acquire all outstanding shares of Cadence Pharmaceuticals, Inc. for $14.00 per share in cash or approximately $1.3 billion on a fully diluted basis, which represents a 32% premium to the trailing 30-trading-day volume weighted average price (VWAP) of $10.62 per share for Cadence Pharmaceuticals, Inc.
The American Association for Cancer Research announced today that Carey Anders, MD, assistant professor of medicine and a member of UNC Lineberger Comprehensive Cancer Center will receive a Breast Cancer Research Foundation-AACR Grant for Translational Breast Cancer Research. The $181,000 grant will be presented at the organization's 102nd Annual Meeting, to be held in Orlando, Florida, April 2-6.
A new breast imaging technique pioneered at Mayo Clinic nearly quadruples detection rates of invasive breast cancers in women with dense breast tissue, according to the results of a major study published this week in the American Journal of Roentgenology.
Researchers have identified a gene that appears to increase a person's risk of developing late-onset Alzheimer's disease, the most common type of Alzheimer's disease. The research will be presented as part of the late-breaking science program at the American Academy of Neurology's 62nd Annual Meeting in Toronto, April 10 - 17, 2010.
› Verified 5 days ago